Swiss Life Asset Management Ltd Buys 8,483 Shares of Lam Research Corporation $LRCX

Swiss Life Asset Management Ltd boosted its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 1.6% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 540,813 shares of the semiconductor company’s stock after purchasing an additional 8,483 shares during the period. Swiss Life Asset Management Ltd’s holdings in Lam Research were worth $72,415,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of LRCX. Stance Capital LLC bought a new stake in shares of Lam Research during the 3rd quarter worth approximately $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research in the second quarter valued at $27,000. Triumph Capital Management bought a new position in shares of Lam Research in the third quarter valued at $27,000. Strategic Wealth Investment Group LLC acquired a new position in Lam Research during the second quarter worth $29,000. Finally, Delos Wealth Advisors LLC acquired a new position in Lam Research during the second quarter worth $30,000. 84.61% of the stock is currently owned by institutional investors.

Lam Research Trading Down 0.8%

LRCX stock opened at $224.71 on Thursday. Lam Research Corporation has a one year low of $56.32 and a one year high of $256.68. The stock has a market cap of $280.61 billion, a price-to-earnings ratio of 46.05, a price-to-earnings-growth ratio of 2.44 and a beta of 1.77. The company has a fifty day moving average price of $226.06 and a two-hundred day moving average price of $175.71. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.10. The company had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The company’s revenue was up 22.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Equities analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be issued a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s dividend payout ratio is currently 21.31%.

Analyst Upgrades and Downgrades

Several research firms have issued reports on LRCX. Susquehanna set a $325.00 price target on shares of Lam Research and gave the stock a “positive” rating in a research report on Thursday, January 29th. Mizuho set a $265.00 price objective on shares of Lam Research in a research note on Wednesday, January 28th. Needham & Company LLC upped their target price on shares of Lam Research from $250.00 to $300.00 and gave the company a “buy” rating in a report on Thursday, January 29th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $290.00 target price (up from $260.00) on shares of Lam Research in a research note on Thursday, January 29th. Finally, B. Riley Financial reiterated a “buy” rating on shares of Lam Research in a report on Thursday, January 15th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, Lam Research currently has a consensus rating of “Moderate Buy” and a consensus target price of $245.35.

Insiders Place Their Bets

In other news, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the transaction, the chief financial officer owned 1,081,705 shares in the company, valued at approximately $242,334,371.15. This trade represents a 4.42% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Eric Brandt sold 35,000 shares of Lam Research stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the sale, the director directly owned 253,705 shares of the company’s stock, valued at approximately $57,235,848. The trade was a 12.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 130,886 shares of company stock worth $29,658,802 over the last three months. Insiders own 0.31% of the company’s stock.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.